Products

Based on the unique understanding of China pharmaceutical market and the introduction ability of Multinational Companies’ technologies and products, Maxmind integrates international and domestic resources by building a bridge linking China market and international innovations.

Maxmind has been adopting a higher perspective of analyzing technology and market, licensing in brand, patents or proprietary technologies from international pharmaceutical enterprises on the purpose of quality and management system improvement, has forged a strong portfolio of products with practical and innovative characteristics.

In addition to the license-in of technology and brand, Maxmind Pharma is also enriching the company's product pipeline through independent development.

A manufacturer and distributor of chocolates, confectionery, health food and drugs with an annual sales of 400 billion Yen and more than 6,000 employees.

Being the sixth largest pharmaceuticals company in Japan, MT Pharma is a subsidiary held by Mitsubishi Chemical Holdings, a member of Fortune Global 500.

With a history of over 70 years, Double Crane Pharma specializes in R&D, pharmaceutical equipment and API and preparation. At present, there are 48 subsidiaries and over 40,000 employees.

Rafarm is a private Greek company headquartered in Athens, Greece, the company is driven by research and development and innovation and has so far developed more than 100 products and completed the registration or technical licensing of more than 1,000 products worldwide.

WELDING GMBH & CO. KG is privately owned German company headquartered in Hamburg (Germany) and subsidiary in France. Welding was founded in 1955, which has a successful track of business relations in over 60 countries worldwide.

Stanchy, plant-derived polysaccharide microspheres absorbable hemostatic powder is a product planning to register in both China and Europe, which has obtained European CE certification. The marketing team adopts higher perspective to understand technology and market and strives to be the connecting bridge to introduce high-tech medical devices or medical materials into China from Europe, U.S and Japan.

The company continues to provide "safe and effective" drugs to the society, and rolls out a "family medicine cabinet" series of OTC products.

Maxmind's team in Europe, Japan and India are actively introducing more competitive products from around the world into China market.

Maxmind attaches great importance to the R&D. Only with continuous R&D and new products can an enterprise develops sustainably. So far, Maxmind have 18 products under development, ranging from cardiovascular and cerebrovascular system, nutritional supplement, antibiotic and API.

Christmas Tree Plan

In the joy of celebrating Christmas , we promises to release at least a new product at the time every year, So, what product will be expected to pop up from the gift box this year?

Looking forward to ...